| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO | Bio-Rad A Common Stock | +Options Exercise | $204,337 | +613 | +13.35% | $333.34 | 5,206 | Nov 11, 2021 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | +Options Exercise | $166,670 | +500 | +9.6% | $333.34 | 5,706 | Nov 11, 2021 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | +Options Exercise | $227,022 | +433 | +7.59% | $524.30 | 6,139 | Nov 11, 2021 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | -Sell | -$323,919 | -433 | -7.05% | $748.08 | 5,706 | Nov 11, 2021 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | -Sell | -$459,039 | -613 | -10.74% | $748.84 | 5,093 | Nov 11, 2021 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | -Sell | -$375,000 | -500 | -9.82% | $750.00 | 4,593 | Nov 11, 2021 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | +Options Exercise | $95,592 | +600 | +13.06% | $159.32 | 5,193 | Nov 12, 2021 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | +Options Exercise | $518,352 | +2,400 | +46.21% | $215.98 | 7,593 | Nov 12, 2021 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | +Options Exercise | $587,070 | +1,800 | +23.7% | $326.15 | 9,393 | Nov 12, 2021 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | -Sell | -$3,600,240 | -4,800 | -51.1% | $750.05 | 4,593 | Nov 12, 2021 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO | Non-Qualified Stock Option (right to buy) | -Options Exercise | $0 | -433 | -24.99% | $0.00 | 1,300 | Nov 11, 2021 | Bio-Rad A Common Stock | 433 | $524.30 | Direct | F2 |
| transaction | BIO | Non-Qualified Stock Option (right to buy) | -Options Exercise | $0 | -1,113 | -39.98% | $0.00 | 1,671 | Nov 11, 2021 | Bio-Rad A Common Stock | 1,113 | $333.34 | Direct | F3 |
| transaction | BIO | Non-Qualified Stock Option (right to buy) | -Options Exercise | $0 | -1,800 | -60% | $0.00 | 1,200 | Nov 12, 2021 | Bio-Rad A Common Stock | 1,800 | $326.15 | Direct | F4 |
| transaction | BIO | Non-Qualified Stock Option (right to buy) | -Options Exercise | $0 | -2,400 | -80% | $0.00 | 600 | Nov 12, 2021 | Bio-Rad A Common Stock | 2,400 | $215.98 | Direct | F5 |
| transaction | BIO | Non-Qualified Stock Option (right to buy) | -Options Exercise | $0 | -600 | -100% | $0.00 | 0 | Nov 12, 2021 | Bio-Rad A Common Stock | 600 | $159.32 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $750.00 to $750.61, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The option, representing a right to purchase a total of 1,733 shares, became exercisable in four equal annual installments beginning on September 2, 2021, which was the first anniversary of the date on which the option was granted. |
| F3 | The option, representing a right to purchase a total of 2,784 shares, became exercisable in five equal annual installments beginning on September 3, 2020, which was the first anniversary of the date on which the option was granted. |
| F4 | The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 4, 2019, which was the first anniversary of the date on which the option was granted. |
| F5 | The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted. |
| F6 | The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted. |